A 73-year-old man was admitted to our institution because of dysphagia. Upper gastrointestinal
endoscopy revealed a bulky intraluminal polypoid lesion in the cervical esophagus
(Figure [1]). Histological results indicated a sarcoma, and computed tomography (CT) scan revealed
a tumor limited to the esophageal wall. The patient could not undergo surgery because
of cardiac dysfunction, and we decided to perform an endoscopic mucosal resection
(EMR). Using a sclerotherapy needle, we injected serum and adrenaline (1/10) into
the lower part of the tumor in order to separate the mucosal and submucosal layers
from the muscularis tissues. Then we resected the bulky pedunculated tumor (3 × 7
cm; Figure [2]) using a polypectomy loop. Histological and immunohistochemical studies confirmed
that the tumor was a sarcoma (myofibroblastic phenotype). At 1 month later, endoscopy
showed a discrete area of thickness 2 mm that corresponded to the EMR scar. Biopsy
results pointed to an undifferentiated squamous cell carcinoma. In fact the tumor
was mixed (carcinosarcoma), with both carcinomatous and sarcomatous components being
present. A cervical thoracic and abdominal CT scan showed only a small mediastinal
lymph node. There were no cervical lymph nodes, neither was there abnormal thickening
of the esophageal wall, mediastinal infiltration, or hepatic metastasis. The patient
underwent complementary chemoradiotherapy. Radiotherapy consisted of a dose of 60
Gy delivered to the superior third of the esophagus (2 Gy for five sessions per week
for 6 weeks), and the chemotherapy was cisplatyl (20 mg/m2 once a week over 6 weeks). Clinical and biological tolerance of this treatment were
excellent. At 2 months after the end of this treatment, endoscopy and endoscopic ultrasonography
(EUS) showed a normal esophageal wall, and follow-up CT scan confirmed complete resolution.
Since then, we have followed up the patient regularly with clinical examination, CT
scan, and EUS. Complete remission has always been found, and there is no sign of relapse
at 2.5 years after the diagnosis. Carcinosarcoma of the esophagus is a rare malignant
neoplasm, predominantly affecting men in their seventh decade of life [1]. The more favorable prognosis associated with carcinosarcoma compared with other
esophageal neoplasms has been attributed to the early onset of symptoms which leads
to prompt diagnosis, and a lower propensity for tumor invasion [1]. Occurrence of this type of tumor is rather unusual in a patient who has never been
previously treated with esophageal radiotherapy or surgery. To our knowledge this
is the second case of esophageal carcinosarcoma to be successfully treated endoscopically
[2], and the first to be treated by EMR [3]
[4]. This unusual approach was undertaken only because the patient’s general condition
precluded esophagectomy with lymph node dissection which is still the ”gold standard”
treatment [5]
[6]. Similarly, chemoradiotherapy alone could not be considered because of the tumoral
volume and dysphagia. In conclusion, EMR associated with other treatments is an interesting
alternative to surgery for a patient with a large pedunculated esophageal tumor who
cannot undergo operation.
Figure 1 A bulky intraluminal polypoid lesion in the cervical esophagus caused dysphagia. A
tablet and remnants of food can be seen above the tumor.
Figure 2 The bulky pedunculated carcinosarcoma (3 × 7 cm) after resection using a polypectomy
loop.
Endoscopy_UCTN_Code_CCL_1AB_2AC_3AB
Endoscopy_UCTN_Code_TTT_1AO_2AF
